February 08, 2012

CLOSE

To subscribe to updates from this journal click Confirm. Updates will be displayed in your default RSS reader.

Produced and published by Remedica Medical Education and Publishing Limited.

» Contact us

International Journal of Advances in Rheumatology

» Advanced search

Please note that only limited free access to this journal is available in your country or territory.

To access the full content of this article you must purchase it (US$9.49). After payment of this one-off fee, you will gain unrestricted online access to the article and a PDF version sent to your email.

As part of our special introductory offer, after purchasing this article you will have unrestricted access to all the articles in this issue for free!

Registered users can purchase/access the article by logging in below. To register for free click here

Registered users login here:

Email Address:
Password:

If you have forgotten your password click here


0 rating

Scleroderma and Fibrosing Disorders: Advances in Management

Veena Rao, MD¹, and Dinesh Khanna, MD, MS²

Systemic sclerosis (SSc) is associated with major morbidity and mortality. SSc can be a major clinical challenge and this article provides a practical approach to the management and treatment of SSc and its complications. We also discuss a growing number of exciting potential novel approaches to treatment that are moving into the clinical arena in SSc. Int J Adv Rheumatol 2010;8(2):53–62.

Please login or register to continue reading this article

Return to top

Post Page On

LATEST ARTICLES

Leading Articles
- The Risk and Prevention of Tuberculosis: Screening Strategies to Detect Latent Tuberculosis Among Rheumatoid Arthritis Patients Who Use Biologic Therapy
  
  Kevin L Winthrop, MD, MPH
  
  Division of Infectious Diseases, Public Health and Preventive Medicine, Oregon Health & Science University, Portland, OR, USA
  
  It has become clear in recent years that rheumatoid arthritis (RA) patients are at an increased risk for tuberculosis, primarily due to the immunosuppressive therapies used to treat RA.
- Scleroderma and Fibrosing Disorders: Advances in Management
  
  Veena Rao, MD¹, and Dinesh Khanna, MD, MS²
  
  ¹Olive View–UCLA Medical Center and ²UCLA Scleroderma Program, David Geffen School of Medicine, Los Angeles, CA, USA
  
  Systemic sclerosis (SSc) is associated with major morbidity and mortality. SSc can be a major clinical challenge and this article provides a practical approach to the management and treatment of SSc and its complications. We also discuss a growing number of exciting potential novel approaches to treatment that are moving into the clinical arena in SSc.
- The Diagnosis of the Antiphospholipid Syndrome: An Update
  
  Neha Dang, MD¹, Ellis Doan, MD¹, and Silvia S Pierangeli, PhD^1,2
  
  ¹Department of Internal Medicine, and ²Antiphospholipid Standardization Laboratory, Division of Rheumatology, Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX, USA
  
  Antiphospholipid syndrome (APS) is an autoimmune disorder of recurrent thrombosis and/or pregnancy losses that is characterized by the presence of antiphospholipid (aPL) antibodies. It is a multisystem disorder and any organ or system in the body may be affected.
Clinical Reviews
Meeting Reports
- British Society for Rheumatology and British Health Professionals in Rheumatology Annual Meeting 2010
  
  Sarah C Horton, MBChB, MRCP
  
  Birmingham, UK, April 21–23, 2010
  Sarah C Horton, MBChB, MRCP Section of Musculoskeletal Disease, Leeds Institute of Molecular Medicine, University of Leeds, Leeds, UK
  
  This year's British Society for Rheumatology (BSR) and British Health Professionals in Rheumatology (BHPR) Annual Meeting took place in Birmingham, UK, from 21–23 April. The current report recounts some of the highlights, including the "Heberden Oration" and "Heberden Round".

Our most popular articles

READ

The Risk and Prevention of Tuberculosis: Screening Strategies to Detect Latent Tuberculosis Among Rheumatoid Arthritis Patients Who Use Biologic Therapy
(Volume 8 Issue 2 / Leading Articles)
Utility of Imaging in the Diagnosis and Assessment of Axial Spondyloarthritis
(Volume 8 Issue 4 / Leading Articles)
Anti-TNF Therapy in Rheumatoid Arthritis: Were the Promises Fulfilled?
(Volume 1 Issue 3 / Leading Articles)
The Diagnosis of the Antiphospholipid Syndrome: An Update
(Volume 8 Issue 2 / Leading Articles)
Scleroderma and Fibrosing Disorders: Advances in Management
(Volume 8 Issue 2 / Leading Articles)
New Classification Criteria for Spondyloarthritis
(Volume 8 Issue 1 / Leading Articles)

Epigenetics in Rheumatology Research 
(Volume 9 Issue 1 / Leading Articles)
Remission in Inflammatory Arthritis:  Past, Present, and Future 
(Volume 9 Issue 3 / Leading Articles)

The Risk and Prevention of Tuberculosis: Screening Strategies to Detect Latent Tuberculosis Among Rheumatoid Arthritis Patients Who Use Biologic Therapy
(Volume 8 Issue 2 / Leading Articles)

© Remedica 2012. All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without the prior permission of the copyright owners. While every effort is made by the publishers and editorial board to see that no inaccurate or misleading data, opinions, or statements appear in this journal, they wish to make it clear that the material contained in the publication represents a summary of the independent evaluations and opinions of the authors and contributors. As a consequence, the board, publishers, and any supporting company accept no responsibility for the consequences of any such inaccurate or misleading data or statements. Neither do they endorse the content of the publication or the use of any drug or device in a way that lies outside its current licensed application in any territory. For detailed information on any drugs or devices discussed in this publication, readers are advised to consult the manufacturer’s prescribing information.

Produced and published by Remedica Medical Education and Publishing Limited.

February 08, 2012

CLOSE

To subscribe to updates from this journal click Confirm. Updates will be displayed in your default RSS reader.

Produced and published by Remedica Medical Education and Publishing Limited.

» Contact us